Chen, Tao
Tsai, Amy Po Yu
Hur, Seo Am
Wong, Alyson W.
Sadatsafavi, Mohsen
Fisher, Jolene H.
Johannson, Kerri A.
Assayag, Deborah
Morisset, Julie
Shapera, Shane
Khalil, Nasreen
Fell, Charlene D.
Manganas, Helene
Cox, Gerard
To, Teresa
Gershon, Andrea S.
Hambly, Nathan
Halayko, Andrew J.
Wilcox, Pearce G.
Kolb, Martin
Ryerson, Christopher J. http://orcid.org/0000-0003-1049-393X
Funding for this research was provided by:
Boehringer Ingelheim (20R23666)
China Scholarship Council (201906260235)
Article History
Received: 13 May 2021
Accepted: 29 June 2021
First Online: 8 July 2021
Declarations
:
: The research ethics boards of all CARE-PF centers approved this sub-study (coordinating center: Providence Health Care and University of British Columbia Research Ethics Board #H18-00993).
: Not required.
: All authors approved the final version to be published.
: CJR, AW, MRJK, JM, NK, KAJ, MS, SS, MK, CDF, HN and DA report personal fees from Boehringer Ingelheim. NK, SS, DA, MS, MK and HN reports grants from Boehringer Ingelheim. SS reports personal fees and grants from Hoffman LaRoche Canada, grants, personal fees from Astrazeneca Canada, other from Galapagos, other from Galecto Biotech. HN also reports personal fees and grants from Roche, personal fees from Janssen, grants from Bayer. JM also reports personal fees from Hoffman La Roche. MK also reports personal fees and grants from Canadian Pulmonary Fibrosis Foundation, Roche, Prometric and Pieris; grants from Canadian Institute for Health Research; other from ERJ; personal fees from Third Pole, MitoImmune, Algernon, Horizon, DecPro Biopharma, and Abbvie. DA also reports personal fees and grants from Hoffman-La Roche Canada and personal fees from Astra Zeneca. CDF reports personal fees from Roche Canada, other from Novartis, other from Galapagos; KAJ also reports personal fees from Hoffman-La Roche Ltd., grants from The Chest Foundation, grants from University of Calgary Cumming School of Medicine, personal fees from Blade Therapeutics, personal fees from Theravance, personal fees and non-financial support from Three Lakes Foundation, grants from UCB Biopharma SPRL, grants from Pulmonary Fibrosis Society of Calgary. TC, APYT, SAH, HM, GC, PGW, JF, AG, CF, AH and TT report no competing interests.